Nadav Kidron insider trades

Open-market stock purchases and sales by Nadav Kidron, President and CEO at Oramed Pharmaceuticals Inc, from SEC Form 4 filings since Apr 21, 2010.

Track record: 44% of 9 scored buys are up 5% or more since purchase, averaging +4%.

Recent trades

DateStockTradeValue
Sep 24, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Sep 24, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Sep 24, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$621K
Sep 24, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$912K
Sep 24, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$381K
Sep 24, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$790K
Sep 24, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$1.6M
Sep 24, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$1.5M
Aug 21, 2026NNDM Nano Dimension LtdSold (not open market)$15K
Aug 21, 2026NNDM Nano Dimension LtdBought (not open market)—
Mar 30, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)$148K
Mar 25, 2026LFWD Lifeward LtdBought (not open market)—
Mar 17, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Mar 12, 2026ORMP Oramed Pharmaceuticals IncSold (not open market)—
Jan 22, 2026ORMP Oramed Pharmaceuticals IncBought (not open market)—
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—
Dec 31, 2025ORMP Oramed Pharmaceuticals IncBought (not open market)—

Companies traded

  • ORMP Oramed Pharmaceuticals Inc: 11 buys, 3 sales, last Sep 24, 2026
  • NNDM Nano Dimension Ltd: other filings, last Aug 21, 2026
  • LFWD Lifeward Ltd: other filings, last Mar 25, 2026
  • ORMP.OB Oramed Pharmaceuticals Inc: other filings, last Aug 8, 2012

Get free alerts when Nadav Kidron files a new trade →